Skip to main content
SpringerLink
Log in

Axicabtagene ciloleucel

Cytokine release syndrome and development of drug resistance due to loss of CD19 antigen: 2 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Bukhari A, et al. Rapid relapse of large B-cell lymphoma after CD19 directed CAR-T-cell therapy due to CD-19 antigen loss. American Journal of Hematology 94: E273-E275, No. 10, Oct 2019. Available from: URL: http://doi.org/10.1002/ajh.25591 - USA

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Axicabtagene ciloleucel. Reactions Weekly 1777, 47 (2019). https://doi.org/10.1007/s40278-019-70631-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-019-70631-x

Search

Navigation